Thomas E. (Ted) Keim, Jr.

Partner
Ted Keim

Ted Keim's practice focuses on mergers and acquisitions, investment and venture capital transactions, private equity, corporate reorganizations and restructurings, and complex joint venture/company representation matters.  Ted's clients include a broad range of public and privately held companies, both in the United States and globally, across a wide spectrum of industries, including healthcare and life sciences/medical devices, food and beverage, financial and technology services, industrials, automotive, aerospace and defense, retail, and hospitality.

Experience

Representative Matters

  • Represented EMZ portfolio company FotoFinder Systems, Inc., a Germany-based global leader in skin imaging solutions, in connection with its acquisition of DermLite LLC, a U.S.-based handheld dermoscopy device company
  • Representing a European private equity purchaser in bolt-on acquisition of a U.S. medical device business from private equity seller
  • Representing a global consumer products corporation in connection with the divesture of its controlling stake in an Indian public company subsidiary
  • Represented a global hospitality company in various brand affiliation/loyalty agreements
  • Represented a low-carbon cement and concrete technology company in various corporate and commercial matters
  • Represented a European/global consumer and personal care products company in the carve-out acquisition of a sealings and coatings business
  • Represented a private equity-owned sensor and technology business in the sale to a private equity-backed strategic acquiror
  • Represented the purchaser of a flooring products company in the acquisition from a private equity seller
  • Represented a private investor group in its acquisition of a controlling interest in a high-profile sports/media-related property and advised on various corporate and commercial matters
  • Represented a medical technology supplier in connection with its acquisition of a digital health provider of ambulatory cardiac monitoring technologies, and transaction-related Delaware Chancery Court litigation
  • Represented a medical technology supplier in connection with its acquisition of a medical device company
  • Represented a French evergreen investment company in connection with its inaugural U.S. preferred equity investment in a global healthcare firm
  • Represented a multi-stage venture capital fund in its Series C-1 growth investment in a manufacturer of carbon black using natural gas feedstock
  • Represented a privately held U.S. biotechnology company in connection with an investment and share repurchase/tender offer transaction involving more than $500 million in contemplated transaction value and settlement of minority shareholder litigation
  • Represented a medical technology supplier in its acquisition of a Mexico City-based medical device software connectivity developer
  • Represented a global logistics company in connection with the structuring and formation of a joint venture in India
  • Represented a medical device supplier in its acquisition of a medical device integration platform company
  • Represented numerous specialty lenders in connection with equity-related matters regarding various lending and restructuring transactions across multiple industries, including healthcare, home health and addiction treatment, telecommunications, restaurants and hospitality, and home repair and automotive services
  • Represented a research company in an IP evaluation and transfer agreement with a manufacturer, distributor, and solutions provider
  • Represented a Chicago-based family office in connection with the acquisition of a dedicated financial, tax, and consulting services firm and related management transition matters
  • Represented a U.S.-based dental medical device manufacturer in the acquisition of 510(k) FDA approval
  • Represented a wax manufacturer in the sale of a business line to a manufacturing and supply company
  • Represented a healthcare company in its acquisition of an India-based generics injectables pharmaceutical company
  • Represented an investment management firm in the sale of its investment platform to a commercial real estate firm and related portfolio-winddown matters
  • Represented a U.S. commercial airline in a debt and equity investment in an early-stage travel distribution platform and related governance matters
  • Represented a chemical company in its sale to a major American adhesives manufacturing company
  • Represented a pharmaceutical company in its purchase of a pre-filled syringe business
  • Represented a precision motor, motion subsystem, and related electromechanical component company in its acquisition of a manufacturing company specializing in innovative engine/transmission pumps and powder metal components in the global automotive industry from a private equity firm
  • Represented a sensor technology company in its sale to a technology distributor
  • Represented a biopharmaceutical company in the acquisition of an oncology pharmaceutical product portfolio from a pharmaceutical company
  • Represented a U.S. supermarket chain in the sale of its Canadian grocery operations
  • Represented a global fertilizer company in its acquisition of a specialty fertilizer business from an agricultural company
  • Represented a wax manufacturer in various acquisition and disposition transactions
  • Represented a health supplement company in its acquisition of a supplement manufacturing company
  • Represented a multinational conglomerate corporation in various bioenergy/ethanol plant acquisitions
  • Represented a family business and partner's interests in the sale of a global information and insights company to private equity firms
  • Represented a high-pressure die casting aluminum auto parts manufacturer in its sale to a global automotive parts manufacturing company
  • Represented a U.S. drugstore chain in its acquisition of an infusion pharmaceutical company
  • Represented an American industrial holding company and the owner of a private family business in the sale of an industrial holding company to an American multinational conglomerate holding company
  • Represented a pharmaceutical company in its sale to a global biopharma company and, prior thereto, various acquisition, disposition, and fundraising transactions

Insights

Credentials
+

Education

  • J.D. University of Chicago Law School 1993
  • M. Phil. University of Cambridge 1990
  • B.A. summa cum laude Yale University 1989

Bar Admissions

  • Illinois

Court Admissions

  • U.S. District Court for the District of Illinois

Professional Memberships and Activities

  • Member, Advisory Board, Museum of Contemporary Photography, Columbia College
  • Alumni admissions representative, Philips Academy
  • Former member, Auxiliary Board, Art Institute of Chicago

Recognition
+

  • Chambers USA, Corporate/M&A (Band 3), 2009 – 2024
  • ILFR 1000, Notable Practitioner, 2020 – 2022